Back to Search
Start Over
VCL::ROS1 : A Novel ROS1 Oncogenic Fusion Detected on Next Generation Sequencing.
- Source :
-
Clinical Pathology . 8/12/2024, p1-4. 4p. - Publication Year :
- 2024
-
Abstract
- Advanced Non-Small Cell Lung Carcinoma (NSCLC) patients with ROS1 gene rearrangement have shown significant therapeutic responses to tyrosine kinase inhibitors approved by the US Food and Drug Administration, with approximately 40 fusion partners documented in the existing literature. Our report highlights a novel fusion partner of ROS1 that has demonstrated a conclusive response to the current standard of treatment. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 2632010X
- Database :
- Academic Search Index
- Journal :
- Clinical Pathology
- Publication Type :
- Academic Journal
- Accession number :
- 178994123
- Full Text :
- https://doi.org/10.1177/2632010X241269373